*Disseminated on Behalf of GeoVax Labs, Inc. Please see disclosures below. |
| 7 Reasons to Pay Attention to GeoVax Labs |
| | | | | Hey Folks, Here are a few reasons why you should put GeoVax Labs, Inc. (GOVX) on your radar:
1. Versatile platform technology — The MVA platform can be applied across multiple disease targets from a single foundation, rather than being a one-product company. 2. Demonstrated safety track record — MVA has been tested in over 120,000 subjects, including immunocompromised individuals, giving it an established safety profile. 3. Multiple Phase 2 clinical trials underway — Three active COVID-19 trials and a completed Phase 1/2 cancer trial show the pipeline is advancing, not sitting idle. 4. Targeting an underserved patient population — With an estimated 23 million immunocompromised individuals in the U.S. and 250+ million worldwide, GeoVax is going after a market that current mRNA vaccines aren't adequately serving. 5. FDA Orphan Drug status for Gedeptin — This brings reduced fees, faster review, and up to seven years of market exclusivity — meaningful regulatory advantages for a small company. 6. FDA directly funded the Gedeptin clinical trial — The Phase 1/2 trial was funded through the FDA's Orphan Products Clinical Trials Grants Program, a notable external validation. 7. Encouraging preclinical cancer data — 57% tumor growth reduction in one study and 100% prevention of tumor recurrence in another, both compared to untreated controls.
Anyways...
That's all for now!
Until Next Time, -ZT Team | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Disseminated on Behalf of GeoVax Labs, Inc. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| This email was sent to indra21poetra@gmail.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated fifteen thousand USD by ACH Bank Transfer by TD Media LLC to distribute media via email and SMS on behalf of GeoVax Labs, Inc. (GOVX) from February 17, 2026 to February 18, 2026. ZipTrader has been compensated five thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for GeoVax Labs, Inc. (GOVX) from March 11, 2025 to March 12, 2025. ZipTrader may receive additional campaigns in the future by TD Media LLC to distribute media for GeoVax Labs, Inc. (GOVX). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in GeoVax Labs, Inc. (GOVX). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of GeoVax Labs, Inc. (GOVX), increased trading volume, and possibly an increased share price of GeoVax Labs, Inc. (GOVX), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
Tidak ada komentar:
Posting Komentar